AR

Anubhav Rai

Active Director Director DIN 09709035
DIN 09709035 First appointment Aug 2022 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Aug 2022
Shareholding value Locked Premium profile

About Anubhav Rai

Anubhav Rai has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Oshawa Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09709035
Primary Designation Director
First Appointment 20 Aug 2022
Oldest Company Age 3 yrs

Current companies

Company Designation Appointment Founded Status
Oshawa Pharma Private Limited U24290UP2022PTC169217
Director 20 Aug 2022 2022 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Oshawa Pharma Private Limited
Premium access

Shareholding and investment profile for Anubhav Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anubhav Rai

Anubhav Rai has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Oshawa Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Anubhav Rai is associated with 1 company as Director.

Anubhav Rai has expertise in General Business.

Anubhav Rai has 3 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available